Kdo2-lipid A, as the bioactive center of LPS, is known to be responsible for the toxic effects of infections, and is recognized by the Toll-like receptor 4 (TLR4)/myeloid differentiation protein 2 (MD-2) complex [12, 36, 37]. Here, LY96 is linked to infection.